BRPI0602179A - composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação - Google Patents

composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação

Info

Publication number
BRPI0602179A
BRPI0602179A BRPI0602179-4A BRPI0602179A BRPI0602179A BR PI0602179 A BRPI0602179 A BR PI0602179A BR PI0602179 A BRPI0602179 A BR PI0602179A BR PI0602179 A BRPI0602179 A BR PI0602179A
Authority
BR
Brazil
Prior art keywords
combination
aceclofenac
cyclobenzaprine
pharmaceutical composition
relates
Prior art date
Application number
BRPI0602179-4A
Other languages
English (en)
Inventor
Dante Junior Alario
Original Assignee
Biolab Sanus Farmaceutica Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolab Sanus Farmaceutica Ltda filed Critical Biolab Sanus Farmaceutica Ltda
Priority to BRPI0602179-4A priority Critical patent/BRPI0602179A/pt
Priority to US12/227,971 priority patent/US8835495B2/en
Priority to EP07719307A priority patent/EP2034829A4/en
Priority to JP2009513520A priority patent/JP2009539776A/ja
Priority to PCT/BR2007/000139 priority patent/WO2007140555A1/en
Priority to MX2008015323A priority patent/MX2008015323A/es
Publication of BRPI0602179A publication Critical patent/BRPI0602179A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOS IçãO FARMACêUTICA COMPREENDENDO CICLOBENZAPRINA E ACECLOFENACO EM COMBINAçãO. A presente invenção se refere a uma combinação de ingredientes ativos. Mais especificamente: a uma combinação de ciclobenzaprina com aceclofenaco. Adicionalmente a presente invenção também se refere ao uso de aceclofenaco e de ciclobenzaprina, conjuntamente, na preparação de um medicamento útil no tratamento de enfermidades musculares dolorosas, bem como a um método de tratamento de enfermidades musculares dolorosas utilizando a combinação de aceclofenaco e ciclobenzaprina.
BRPI0602179-4A 2006-06-08 2006-06-08 composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação BRPI0602179A (pt)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BRPI0602179-4A BRPI0602179A (pt) 2006-06-08 2006-06-08 composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
US12/227,971 US8835495B2 (en) 2006-06-08 2007-06-06 Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association
EP07719307A EP2034829A4 (en) 2006-06-08 2007-06-06 PHARMACEUTICAL COMPOSITION COMPRISING CYCLOBENZAPRIN AND ACECLOFENAC IN ASSOCIATION
JP2009513520A JP2009539776A (ja) 2006-06-08 2007-06-06 シクロベンザプリンおよびアセクロフェナクの組み合わせを含んでいる薬学的組成物
PCT/BR2007/000139 WO2007140555A1 (en) 2006-06-08 2007-06-06 Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association
MX2008015323A MX2008015323A (es) 2006-06-08 2007-06-06 Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0602179-4A BRPI0602179A (pt) 2006-06-08 2006-06-08 composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação

Publications (1)

Publication Number Publication Date
BRPI0602179A true BRPI0602179A (pt) 2008-01-22

Family

ID=38800984

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0602179-4A BRPI0602179A (pt) 2006-06-08 2006-06-08 composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação

Country Status (6)

Country Link
US (1) US8835495B2 (pt)
EP (1) EP2034829A4 (pt)
JP (1) JP2009539776A (pt)
BR (1) BRPI0602179A (pt)
MX (1) MX2008015323A (pt)
WO (1) WO2007140555A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010133961A1 (en) 2009-05-22 2010-11-25 Inventia Healthcare Private Limited Extended release compositions of cyclobenzaprine
ITMI20110558A1 (it) 2011-04-06 2012-10-07 Campiglio Consulting Srl Composizione farmaceutica contenente ciclobenzaprina adatta alla somministrazione endonasale
US9346742B2 (en) * 2012-05-10 2016-05-24 Cellix Bio Private Limited Compositions and methods for the treatment of fibromyalgia pain
CN109316457B (zh) * 2018-11-26 2021-07-13 正大制药（青岛）有限公司 一种盐酸环苯扎林缓释制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191624A (en) * 1978-10-04 1983-09-30 Merck & Co Inc Skeletal muscle relaxant containing cyclobenzaprine and diflunisal
WO1995000180A1 (de) * 1993-06-17 1995-01-05 Farco-Pharma Gesellschaft Mit Beschränkter Haftung Pharmazeutische Präparate Verfahren zur herstellung einer sterilen bereitschaftspackung und behältnis für eine solche bereitschaftspackung
EP1017370B1 (en) * 1997-09-11 2003-10-29 Nycomed Danmark ApS MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
DE19927688A1 (de) * 1999-06-17 2000-12-21 Gruenenthal Gmbh Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
US20020066691A1 (en) * 2000-12-04 2002-06-06 Varon Steven C. Therapy pack
WO2003030818A2 (en) * 2001-10-05 2003-04-17 Pichit Suvanprakorn Active agents using liposome beads

Also Published As

Publication number Publication date
EP2034829A1 (en) 2009-03-18
EP2034829A4 (en) 2009-12-02
WO2007140555A1 (en) 2007-12-13
US20090306204A1 (en) 2009-12-10
JP2009539776A (ja) 2009-11-19
US8835495B2 (en) 2014-09-16
MX2008015323A (es) 2009-04-22

Similar Documents

Publication Publication Date Title
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
BR112014031394A2 (pt) composições e métodos para absorção transmucosa
CU20070203A7 (es) Composición farmacéutica que comprende una difenilurea sustituida con omega-carboxiarilo para el tratamiento del cáncer
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
BRPI0906181A2 (pt) "método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer"
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
MX2010009623A (es) Derivados de 1-bencil-3-hidroximetilindazol novedosos y su uso en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
UA105644C2 (uk) Способи лікування легеневих порушень складами ліпосомального амікацину
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
BR112012006283A2 (pt) formulação de adamts13 estabilizada, método para fabricar uma formulação de adamts13 estabilizada, kit, e métodos para tratar ou prevenir uma doença e para tratar ou previnir um enfarte
MX2010009625A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
AR060019A1 (es) Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
ATE494889T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
MX2010009624A (es) Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1 y cx3cr1.
AR079000A1 (es) Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas
BRPI0602179A (pt) composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
BRPI0607976A2 (pt) composição farmacêutica e uso de uma composição
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
AR086491A1 (es) Composicion farmaceutica que comprende fexofenadina

Legal Events

Date Code Title Description
B25C Requirement related to requested transfer of rights

Owner name: BIOLAB SANUS FARMACEUTICA LTDA. (BR/SP)

Free format text: A FIM DE ATENDER O PEDIDO DE TRANSFERENCIA SOLICITADO NA PETICAO NO 020080140615/RJ DE 10/11/2008, QUEIRA O INTERESSADO APRESENTAR O CONTRATO SOCIAL DA EMPRESA CEDENTE, LEGITIMANDO AS ASSINATURAS E OS PODERES DEMONSTRADOS NO TERMO DE CESSAO E TRANSFERENCIA.

B25B Requested transfer of rights rejected

Owner name: BIOLAB SANUS FARMACEUTICA LTDA. (BR/SP)

Free format text: INDEFERIDA A TRANSFERENCIA SOLICITADA ATRAVES DA PETICAO NO 020080140615/RJ DE 10/11/2008, EM VIRTUDE DO NAO CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI 1992 DE 10/03/2009.

B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: CONFORME RESOLUCAO 124/06, O DEPOSITANTE DEVERA COMPLEMENTAR A RETRIBUICAO DA 4A ANUIDADE, REFERENTE A GUIA DE RECOLHIMENTO 22090349194-7.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE N?O FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL